National Health Investors Stock Total Asset
WX6 Stock | 73.50 1.50 2.08% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National |
National Health Investors Company Total Asset Analysis
National Health's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current National Health Total Asset | 2.51 B |
Most of National Health's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition |
Based on the latest financial disclosure, National Health Investors has a Total Asset of 2.51 B. This is much higher than that of the sector and significantly higher than that of the Total Asset industry. The total asset for all Germany stocks is notably lower than that of the firm.
National Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in total asset category among its peers.
National Fundamentals
Current Valuation | 3.32 B | |||
Price To Book | 1.82 X | |||
Price To Sales | 8.98 X | |||
Revenue | 278.19 M | |||
EBITDA | 178.82 M | |||
Net Income | 66.4 M | |||
Total Debt | 1.15 B | |||
Cash Flow From Operations | 185.34 M | |||
Market Capitalization | 2.24 B | |||
Total Asset | 2.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.09 % | |||
Net Asset | 2.51 B |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for National Stock Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.